Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-22-004988

Chairman & CEO sold 32,550 shares at an average $112.36 ($3,657,321)

  • Chairman & CEO acquired 45,050 shares (option exercise)
  • Chairman & CEO gave 12,500 shares (gift)
  • Chairman & CEO gave 12,500 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

MUSSALLEM MICHAEL A · Chairman & CEO

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2022-03-22 Exercise or conversion : show line 1 in the form +45,050 $21.76 $980,288 124,321.82 D
2022-03-22 Sale : show line 2 in the form −2,300 $109.79 $252,517 122,021.82 D
2022-03-22 Sale : show line 3 in the form −3,000 $110.86 $332,580 119,021.82 D
2022-03-22 Sale : show line 4 in the form −4,301 $112.06 $481,970 114,720.82 D
2022-03-22 Gift : show line 5 in the form −12,500 102,220.82 D
2022-03-22 Sale : show line 6 in the form −22,949 $112.87 $2,590,254 79,271.82 D
2022-03-22 Gift : show line 7 in the form +12,500 3,381,517 I
Open-market sales · 32,550 sh · avg $112.36 · $3,657,321

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-03-22 Exercise or conversion : show line 8 in the form Employee Stock Option (Right to Acquire) −45,050 $21.76 2022-05-13 45,050 90,100 D
Loading xslF345X03/doc4.xml…